Global Insomnia Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Publisher Name :
Date: 04-Aug-2022
No. of pages: 114

The Insomnia Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Insomnia Therapy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Insomnia Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Non-pharmacological Therapy segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Insomnia Therapy include Merck & Co., Sanofi, Pfizer, Takeda Pharmaceutical Company Ltd., and Purdue Pharmaceuticals L.P., etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Insomnia Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

- Non-pharmacological Therapy

- Pharmacological Therapy

Market segment by Application, can be divided into

- Hospital

- Ambulatory Surgical Center

- Home Care

Market segment by players, this report covers

- Merck & Co.

- Sanofi

- Pfizer

- Takeda Pharmaceutical Company Ltd.

- Purdue Pharmaceuticals L.P.

- Eisai, Co. Ltd.

- Meda Consumer Healthcare

- Pernix Therapeutics

- Vanda Pharmaceuticals

- ECR Pharmaceuticals

- Fidia Farmaceutici

- Dainippon Sumitomo

- Biocodex

- Eli Lilly and Company

- Ebb Therapeutics

Market segment by regions, regional analysis covers

- North America (United States, Canada, and Mexico)

- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

- South America (Brazil, Argentina, Rest of South America)

- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Insomnia Therapy product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Insomnia Therapy, with revenue, gross margin and global market share of Insomnia Therapy from 2019 to 2022.

Chapter 3, the Insomnia Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Insomnia Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Insomnia Therapy research findings and conclusion, appendix and data source.

Global Insomnia Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Insomnia Therapy
1.2 Classification of Insomnia Therapy by Type
1.2.1 Overview: Global Insomnia Therapy Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Insomnia Therapy Revenue Market Share by Type in 2021
1.2.3 Non-pharmacological Therapy
1.2.4 Pharmacological Therapy
1.3 Global Insomnia Therapy Market by Application
1.3.1 Overview: Global Insomnia Therapy Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Ambulatory Surgical Center
1.3.4 Home Care
1.4 Global Insomnia Therapy Market Size & Forecast
1.5 Global Insomnia Therapy Market Size and Forecast by Region
1.5.1 Global Insomnia Therapy Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Insomnia Therapy Market Size by Region, (2017-2022)
1.5.3 North America Insomnia Therapy Market Size and Prospect (2017-2028)
1.5.4 Europe Insomnia Therapy Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Insomnia Therapy Market Size and Prospect (2017-2028)
1.5.6 South America Insomnia Therapy Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Insomnia Therapy Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Insomnia Therapy Market Drivers
1.6.2 Insomnia Therapy Market Restraints
1.6.3 Insomnia Therapy Trends Analysis
2 Company Profiles
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business
2.1.3 Merck & Co. Insomnia Therapy Product and Solutions
2.1.4 Merck & Co. Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Merck & Co. Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Insomnia Therapy Product and Solutions
2.2.4 Sanofi Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Insomnia Therapy Product and Solutions
2.3.4 Pfizer Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Takeda Pharmaceutical Company Ltd.
2.4.1 Takeda Pharmaceutical Company Ltd. Details
2.4.2 Takeda Pharmaceutical Company Ltd. Major Business
2.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product and Solutions
2.4.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Takeda Pharmaceutical Company Ltd. Recent Developments and Future Plans
2.5 Purdue Pharmaceuticals L.P.
2.5.1 Purdue Pharmaceuticals L.P. Details
2.5.2 Purdue Pharmaceuticals L.P. Major Business
2.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Product and Solutions
2.5.4 Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Purdue Pharmaceuticals L.P. Recent Developments and Future Plans
2.6 Eisai, Co. Ltd.
2.6.1 Eisai, Co. Ltd. Details
2.6.2 Eisai, Co. Ltd. Major Business
2.6.3 Eisai, Co. Ltd. Insomnia Therapy Product and Solutions
2.6.4 Eisai, Co. Ltd. Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Eisai, Co. Ltd. Recent Developments and Future Plans
2.7 Meda Consumer Healthcare
2.7.1 Meda Consumer Healthcare Details
2.7.2 Meda Consumer Healthcare Major Business
2.7.3 Meda Consumer Healthcare Insomnia Therapy Product and Solutions
2.7.4 Meda Consumer Healthcare Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Meda Consumer Healthcare Recent Developments and Future Plans
2.8 Pernix Therapeutics
2.8.1 Pernix Therapeutics Details
2.8.2 Pernix Therapeutics Major Business
2.8.3 Pernix Therapeutics Insomnia Therapy Product and Solutions
2.8.4 Pernix Therapeutics Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Pernix Therapeutics Recent Developments and Future Plans
2.9 Vanda Pharmaceuticals
2.9.1 Vanda Pharmaceuticals Details
2.9.2 Vanda Pharmaceuticals Major Business
2.9.3 Vanda Pharmaceuticals Insomnia Therapy Product and Solutions
2.9.4 Vanda Pharmaceuticals Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Vanda Pharmaceuticals Recent Developments and Future Plans
2.10 ECR Pharmaceuticals
2.10.1 ECR Pharmaceuticals Details
2.10.2 ECR Pharmaceuticals Major Business
2.10.3 ECR Pharmaceuticals Insomnia Therapy Product and Solutions
2.10.4 ECR Pharmaceuticals Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 ECR Pharmaceuticals Recent Developments and Future Plans
2.11 Fidia Farmaceutici
2.11.1 Fidia Farmaceutici Details
2.11.2 Fidia Farmaceutici Major Business
2.11.3 Fidia Farmaceutici Insomnia Therapy Product and Solutions
2.11.4 Fidia Farmaceutici Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Fidia Farmaceutici Recent Developments and Future Plans
2.12 Dainippon Sumitomo
2.12.1 Dainippon Sumitomo Details
2.12.2 Dainippon Sumitomo Major Business
2.12.3 Dainippon Sumitomo Insomnia Therapy Product and Solutions
2.12.4 Dainippon Sumitomo Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Dainippon Sumitomo Recent Developments and Future Plans
2.13 Biocodex
2.13.1 Biocodex Details
2.13.2 Biocodex Major Business
2.13.3 Biocodex Insomnia Therapy Product and Solutions
2.13.4 Biocodex Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Biocodex Recent Developments and Future Plans
2.14 Eli Lilly and Company
2.14.1 Eli Lilly and Company Details
2.14.2 Eli Lilly and Company Major Business
2.14.3 Eli Lilly and Company Insomnia Therapy Product and Solutions
2.14.4 Eli Lilly and Company Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Eli Lilly and Company Recent Developments and Future Plans
2.15 Ebb Therapeutics
2.15.1 Ebb Therapeutics Details
2.15.2 Ebb Therapeutics Major Business
2.15.3 Ebb Therapeutics Insomnia Therapy Product and Solutions
2.15.4 Ebb Therapeutics Insomnia Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Ebb Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Insomnia Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Insomnia Therapy Players Market Share in 2021
3.2.2 Top 10 Insomnia Therapy Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Insomnia Therapy Players Head Office, Products and Services Provided
3.4 Insomnia Therapy Mergers & Acquisitions
3.5 Insomnia Therapy New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Insomnia Therapy Revenue and Market Share by Type (2017-2022)
4.2 Global Insomnia Therapy Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Insomnia Therapy Revenue Market Share by Application (2017-2022)
5.2 Global Insomnia Therapy Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Insomnia Therapy Revenue by Type (2017-2028)
6.2 North America Insomnia Therapy Revenue by Application (2017-2028)
6.3 North America Insomnia Therapy Market Size by Country
6.3.1 North America Insomnia Therapy Revenue by Country (2017-2028)
6.3.2 United States Insomnia Therapy Market Size and Forecast (2017-2028)
6.3.3 Canada Insomnia Therapy Market Size and Forecast (2017-2028)
6.3.4 Mexico Insomnia Therapy Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Insomnia Therapy Revenue by Type (2017-2028)
7.2 Europe Insomnia Therapy Revenue by Application (2017-2028)
7.3 Europe Insomnia Therapy Market Size by Country
7.3.1 Europe Insomnia Therapy Revenue by Country (2017-2028)
7.3.2 Germany Insomnia Therapy Market Size and Forecast (2017-2028)
7.3.3 France Insomnia Therapy Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Insomnia Therapy Market Size and Forecast (2017-2028)
7.3.5 Russia Insomnia Therapy Market Size and Forecast (2017-2028)
7.3.6 Italy Insomnia Therapy Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Insomnia Therapy Revenue by Type (2017-2028)
8.2 Asia-Pacific Insomnia Therapy Revenue by Application (2017-2028)
8.3 Asia-Pacific Insomnia Therapy Market Size by Region
8.3.1 Asia-Pacific Insomnia Therapy Revenue by Region (2017-2028)
8.3.2 China Insomnia Therapy Market Size and Forecast (2017-2028)
8.3.3 Japan Insomnia Therapy Market Size and Forecast (2017-2028)
8.3.4 South Korea Insomnia Therapy Market Size and Forecast (2017-2028)
8.3.5 India Insomnia Therapy Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Insomnia Therapy Market Size and Forecast (2017-2028)
8.3.7 Australia Insomnia Therapy Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Insomnia Therapy Revenue by Type (2017-2028)
9.2 South America Insomnia Therapy Revenue by Application (2017-2028)
9.3 South America Insomnia Therapy Market Size by Country
9.3.1 South America Insomnia Therapy Revenue by Country (2017-2028)
9.3.2 Brazil Insomnia Therapy Market Size and Forecast (2017-2028)
9.3.3 Argentina Insomnia Therapy Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Insomnia Therapy Revenue by Type (2017-2028)
10.2 Middle East & Africa Insomnia Therapy Revenue by Application (2017-2028)
10.3 Middle East & Africa Insomnia Therapy Market Size by Country
10.3.1 Middle East & Africa Insomnia Therapy Revenue by Country (2017-2028)
10.3.2 Turkey Insomnia Therapy Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Insomnia Therapy Market Size and Forecast (2017-2028)
10.3.4 UAE Insomnia Therapy Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Insomnia Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Insomnia Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Insomnia Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Insomnia Therapy Revenue (USD Million) by Region (2017-2022)
Table 5. Global Insomnia Therapy Revenue Market Share by Region (2023-2028)
Table 6. Merck & Co. Corporate Information, Head Office, and Major Competitors
Table 7. Merck & Co. Major Business
Table 8. Merck & Co. Insomnia Therapy Product and Solutions
Table 9. Merck & Co. Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Sanofi Corporate Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Insomnia Therapy Product and Solutions
Table 13. Sanofi Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Pfizer Corporate Information, Head Office, and Major Competitors
Table 15. Pfizer Major Business
Table 16. Pfizer Insomnia Therapy Product and Solutions
Table 17. Pfizer Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Takeda Pharmaceutical Company Ltd. Corporate Information, Head Office, and Major Competitors
Table 19. Takeda Pharmaceutical Company Ltd. Major Business
Table 20. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product and Solutions
Table 21. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Purdue Pharmaceuticals L.P. Corporate Information, Head Office, and Major Competitors
Table 23. Purdue Pharmaceuticals L.P. Major Business
Table 24. Purdue Pharmaceuticals L.P. Insomnia Therapy Product and Solutions
Table 25. Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Eisai, Co. Ltd. Corporate Information, Head Office, and Major Competitors
Table 27. Eisai, Co. Ltd. Major Business
Table 28. Eisai, Co. Ltd. Insomnia Therapy Product and Solutions
Table 29. Eisai, Co. Ltd. Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Meda Consumer Healthcare Corporate Information, Head Office, and Major Competitors
Table 31. Meda Consumer Healthcare Major Business
Table 32. Meda Consumer Healthcare Insomnia Therapy Product and Solutions
Table 33. Meda Consumer Healthcare Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Pernix Therapeutics Corporate Information, Head Office, and Major Competitors
Table 35. Pernix Therapeutics Major Business
Table 36. Pernix Therapeutics Insomnia Therapy Product and Solutions
Table 37. Pernix Therapeutics Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Vanda Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. Vanda Pharmaceuticals Major Business
Table 40. Vanda Pharmaceuticals Insomnia Therapy Product and Solutions
Table 41. Vanda Pharmaceuticals Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. ECR Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 43. ECR Pharmaceuticals Major Business
Table 44. ECR Pharmaceuticals Insomnia Therapy Product and Solutions
Table 45. ECR Pharmaceuticals Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Fidia Farmaceutici Corporate Information, Head Office, and Major Competitors
Table 47. Fidia Farmaceutici Major Business
Table 48. Fidia Farmaceutici Insomnia Therapy Product and Solutions
Table 49. Fidia Farmaceutici Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Dainippon Sumitomo Corporate Information, Head Office, and Major Competitors
Table 51. Dainippon Sumitomo Major Business
Table 52. Dainippon Sumitomo Insomnia Therapy Product and Solutions
Table 53. Dainippon Sumitomo Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Biocodex Corporate Information, Head Office, and Major Competitors
Table 55. Biocodex Major Business
Table 56. Biocodex Insomnia Therapy Product and Solutions
Table 57. Biocodex Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors
Table 59. Eli Lilly and Company Major Business
Table 60. Eli Lilly and Company Insomnia Therapy Product and Solutions
Table 61. Eli Lilly and Company Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Ebb Therapeutics Corporate Information, Head Office, and Major Competitors
Table 63. Ebb Therapeutics Major Business
Table 64. Ebb Therapeutics Insomnia Therapy Product and Solutions
Table 65. Ebb Therapeutics Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Global Insomnia Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 67. Global Insomnia Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 68. Breakdown of Insomnia Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Insomnia Therapy Players Head Office, Products and Services Provided
Table 70. Insomnia Therapy Mergers & Acquisitions in the Past Five Years
Table 71. Insomnia Therapy New Entrants and Expansion Plans
Table 72. Global Insomnia Therapy Revenue (USD Million) by Type (2017-2022)
Table 73. Global Insomnia Therapy Revenue Share by Type (2017-2022)
Table 74. Global Insomnia Therapy Revenue Forecast by Type (2023-2028)
Table 75. Global Insomnia Therapy Revenue by Application (2017-2022)
Table 76. Global Insomnia Therapy Revenue Forecast by Application (2023-2028)
Table 77. North America Insomnia Therapy Revenue by Type (2017-2022) & (USD Million)
Table 78. North America Insomnia Therapy Revenue by Type (2023-2028) & (USD Million)
Table 79. North America Insomnia Therapy Revenue by Application (2017-2022) & (USD Million)
Table 80. North America Insomnia Therapy Revenue by Application (2023-2028) & (USD Million)
Table 81. North America Insomnia Therapy Revenue by Country (2017-2022) & (USD Million)
Table 82. North America Insomnia Therapy Revenue by Country (2023-2028) & (USD Million)
Table 83. Europe Insomnia Therapy Revenue by Type (2017-2022) & (USD Million)
Table 84. Europe Insomnia Therapy Revenue by Type (2023-2028) & (USD Million)
Table 85. Europe Insomnia Therapy Revenue by Application (2017-2022) & (USD Million)
Table 86. Europe Insomnia Therapy Revenue by Application (2023-2028) & (USD Million)
Table 87. Europe Insomnia Therapy Revenue by Country (2017-2022) & (USD Million)
Table 88. Europe Insomnia Therapy Revenue by Country (2023-2028) & (USD Million)
Table 89. Asia-Pacific Insomnia Therapy Revenue by Type (2017-2022) & (USD Million)
Table 90. Asia-Pacific Insomnia Therapy Revenue by Type (2023-2028) & (USD Million)
Table 91. Asia-Pacific Insomnia Therapy Revenue by Application (2017-2022) & (USD Million)
Table 92. Asia-Pacific Insomnia Therapy Revenue by Application (2023-2028) & (USD Million)
Table 93. Asia-Pacific Insomnia Therapy Revenue by Region (2017-2022) & (USD Million)
Table 94. Asia-Pacific Insomnia Therapy Revenue by Region (2023-2028) & (USD Million)
Table 95. South America Insomnia Therapy Revenue by Type (2017-2022) & (USD Million)
Table 96. South America Insomnia Therapy Revenue by Type (2023-2028) & (USD Million)
Table 97. South America Insomnia Therapy Revenue by Application (2017-2022) & (USD Million)
Table 98. South America Insomnia Therapy Revenue by Application (2023-2028) & (USD Million)
Table 99. South America Insomnia Therapy Revenue by Country (2017-2022) & (USD Million)
Table 100. South America Insomnia Therapy Revenue by Country (2023-2028) & (USD Million)
Table 101. Middle East & Africa Insomnia Therapy Revenue by Type (2017-2022) & (USD Million)
Table 102. Middle East & Africa Insomnia Therapy Revenue by Type (2023-2028) & (USD Million)
Table 103. Middle East & Africa Insomnia Therapy Revenue by Application (2017-2022) & (USD Million)
Table 104. Middle East & Africa Insomnia Therapy Revenue by Application (2023-2028) & (USD Million)
Table 105. Middle East & Africa Insomnia Therapy Revenue by Country (2017-2022) & (USD Million)
Table 106. Middle East & Africa Insomnia Therapy Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Insomnia Therapy Picture
Figure 2. Global Insomnia Therapy Revenue Market Share by Type in 2021
Figure 3. Non-pharmacological Therapy
Figure 4. Pharmacological Therapy
Figure 5. Insomnia Therapy Revenue Market Share by Application in 2021
Figure 6. Hospital Picture
Figure 7. Ambulatory Surgical Center Picture
Figure 8. Home Care Picture
Figure 9. Global Insomnia Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Insomnia Therapy Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Insomnia Therapy Revenue Market Share by Region (2017-2028)
Figure 12. Global Insomnia Therapy Revenue Market Share by Region in 2021
Figure 13. North America Insomnia Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Insomnia Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Insomnia Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Insomnia Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Insomnia Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Insomnia Therapy Market Drivers
Figure 19. Insomnia Therapy Market Restraints
Figure 20. Insomnia Therapy Market Trends
Figure 21. Merck & Co. Recent Developments and Future Plans
Figure 22. Sanofi Recent Developments and Future Plans
Figure 23. Pfizer Recent Developments and Future Plans
Figure 24. Takeda Pharmaceutical Company Ltd. Recent Developments and Future Plans
Figure 25. Purdue Pharmaceuticals L.P. Recent Developments and Future Plans
Figure 26. Eisai, Co. Ltd. Recent Developments and Future Plans
Figure 27. Meda Consumer Healthcare Recent Developments and Future Plans
Figure 28. Pernix Therapeutics Recent Developments and Future Plans
Figure 29. Vanda Pharmaceuticals Recent Developments and Future Plans
Figure 30. ECR Pharmaceuticals Recent Developments and Future Plans
Figure 31. Fidia Farmaceutici Recent Developments and Future Plans
Figure 32. Dainippon Sumitomo Recent Developments and Future Plans
Figure 33. Biocodex Recent Developments and Future Plans
Figure 34. Eli Lilly and Company Recent Developments and Future Plans
Figure 35. Ebb Therapeutics Recent Developments and Future Plans
Figure 36. Global Insomnia Therapy Revenue Share by Players in 2021
Figure 37. Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 38. Global Top 3 Players Insomnia Therapy Revenue Market Share in 2021
Figure 39. Global Top 10 Players Insomnia Therapy Revenue Market Share in 2021
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 41. Global Insomnia Therapy Revenue Share by Type in 2021
Figure 42. Global Insomnia Therapy Market Share Forecast by Type (2023-2028)
Figure 43. Global Insomnia Therapy Revenue Share by Application in 2021
Figure 44. Global Insomnia Therapy Market Share Forecast by Application (2023-2028)
Figure 45. North America Insomnia Therapy Sales Market Share by Type (2017-2028)
Figure 46. North America Insomnia Therapy Sales Market Share by Application (2017-2028)
Figure 47. North America Insomnia Therapy Revenue Market Share by Country (2017-2028)
Figure 48. United States Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Canada Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Mexico Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Europe Insomnia Therapy Sales Market Share by Type (2017-2028)
Figure 52. Europe Insomnia Therapy Sales Market Share by Application (2017-2028)
Figure 53. Europe Insomnia Therapy Revenue Market Share by Country (2017-2028)
Figure 54. Germany Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Insomnia Therapy Sales Market Share by Type (2017-2028)
Figure 60. Asia-Pacific Insomnia Therapy Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Insomnia Therapy Revenue Market Share by Region (2017-2028)
Figure 62. China Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South Korea Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Insomnia Therapy Sales Market Share by Type (2017-2028)
Figure 69. South America Insomnia Therapy Sales Market Share by Application (2017-2028)
Figure 70. South America Insomnia Therapy Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East and Africa Insomnia Therapy Sales Market Share by Type (2017-2028)
Figure 74. Middle East and Africa Insomnia Therapy Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Insomnia Therapy Revenue Market Share by Country (2017-2028)
Figure 76. Turkey Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. UAE Insomnia Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
  • Insomnia Therapy - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Insomnia Therapy, with both quantitative and......
  • Global Insomnia Therapy Market Research Report 2023
    Published: 28-Nov-2023        Price: US 2900 Onwards        Pages: 101
    Insomnia is when you aren't sleeping as you should. That can mean you aren't sleeping enough, you aren't sleeping well or you're having trouble falling or staying asleep. For some people, insomnia is a minor inconvenience. According to QYResearch's new survey, global Insomnia Therapy market is projected to reach US$ 4147.8 million in 2029, increasing from US$ 2900 million in 2022, with The CAGR of 5.2% during The period of 2023 to 2029. The growth of The global insomnia marke......
  • Global Zolpidem Tartrate Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Zolpidem Tartrate market: According to our latest research, the global Zolpidem Tartrate market looks promising in the next 5 years. As of 2022, the global Zolpidem Tartrate market was estimated at USD 249.4 million, and it's anticipated to reach USD 296.03 million in 2028, with a CAGR of 2.9% during the forecast years. Zolpidem tartrate tablets, indications for this product are limited to the treatment of severe sleep disorders in the following situ......
  • Global Zolpidem Tartrate Market Insights, Forecast to 2029
    Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 96
    The global Zolpidem Tartrate market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Zolpidem Tartrate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for Zolpidem Tartrate is estimated to increase from $ million in 2023 to reach $ million ......
  • Global Zolpidem Tartrate Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 30-May-2023        Price: US 3260 Onwards        Pages: 129
    Zolpidem tartrate tablets, indications for this product are limited to the treatment of severe sleep disorders in the following situations: incidental insomnia, temporary insomnia The Zolpidem Tartrate market revenue was 249.4 Million USD in 2022, and will reach 296.03 Million USD in 2028, with a CAGR of 2.9% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Zolpidem Tartrate industry, and breaks down according to the......
  • Global Zolpidem Tartrate Market Research Report 2023
    Published: 26-Apr-2023        Price: US 2900 Onwards        Pages: 92
    Highlights The global Zolpidem Tartrate market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Zolpidem Tartrate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. ......
  • Global Insomnia Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 24-Feb-2023        Price: US 3260 Onwards        Pages: 113
    The Insomnia Drugs market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Insomnia Drugs industry, and breaks down according to the type, application, and consumption area of Insomnia Drugs. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading c......
  • Global Insomnia Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 01-Dec-2022        Price: US 3450 Onwards        Pages: 103
    The report focuses on the Insomnia Drugs market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, ......
  • (Post-pandemic Era) - Global Zolpidem Tartrate Market Segment Research Report 2022
    Published: 23-Nov-2022        Price: US 3300 Onwards        Pages: 85
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs